Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
ADC Biotechnology logo — Accelerating solutions for developers to overcome conjugatio...

ADC Biotechnology

Accelerating solutions for developers to overcome conjugation challenges, making new ADC-based anti-cancer drugs faster, simpler, and more cost-effective.

Founded 2010 Venture round Total: $16.33M Biopharma, Biotechnology +1

General Information

Company Name ADC Biotechnology
Founded Year 2010
Industries Biopharma, Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with ADC Biotechnology. To contact ADC Biotechnology, visit adcbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ADC Biotechnology compare?

A PDF of ADC Biotechnology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ADC Biotechnology soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ADC Biotechnology

ADC Biotechnology is a biotech company that aims to expedite the development of anti-cancer drugs through innovative process technology. The company's slogan emphasizes its commitment to overcoming conjugation challenges and facilitating the production of ADC-based therapies. Founded in 2010, ADC Bio operates in the biopharma, biotechnology, and healthcare industries. In November 2018, the company received a significant £2.50M Venture Round investment from a consortium of investors, including Maven Capital Partners, Development Bank of Wales, Downing Ventures, and Seneca Partners. This funding is expected to fuel the company's efforts to streamline the development of ADC therapies, potentially advancing cancer treatment options. With its focus on addressing critical challenges in drug development, ADC Biotechnology is poised to make a meaningful impact in the healthcare industry.

Business keywords: ADC Bio, drug development, process technology, conjugation challenges, antibody-drug conjugate, cancer treatment, pharmaceuticals, innovation, therapeutic antibodies, oncology, biopharmaceuticals

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round £2.50M 4
Maven Capital Partners Development Bank of Wales Downing Ventures
Maven Capital Partners, Development Bank of Wales +2
15 Nov 2018
Venture Round £1.14M 1
Downing LLP
25 Apr 2018
Venture Round £6.00M 4
Maven Capital Partners Development Bank of Wales Acceleris Capital
Maven Capital Partners, Development Bank of Wales +2
25 Sep 2017
Venture Round £6.24M 1
InvestingZone
10 Jul 2017
Grant £103.00K 2
Llywodraeth
Llywodraeth, Denbighshire County Council
09 Dec 2011
Venture Round £350.00K 2
Development Bank of Wales Acceleris Capital
Development Bank of Wales, Acceleris Capital
09 Dec 2011

ADC Biotechnology Alternatives & Competitors

ADC Biotechnology vs
Iksuda Therapeutics
Iksuda Therapeutics United Kingdom

Creating class-leading ADCs with enhanced tumor specificity

Series A
43 employees
Biopharma, Biotechnology
ADC Biotechnology vs
Bright Biologics
Bright Biologics United States

Developing bispecific antibody drug to improve cancer treatment.

6 employees
Biotechnology, Health Care
ADC Biotechnology vs
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. United States

Charting a new dimension in ADC technology

Series B
53 employees
Biotechnology, Health Care

FAQ About ADC Biotechnology

Accelerating solutions for developers to overcome conjugation challenges, making new ADC-based anti-cancer drugs faster, simpler, and more cost-effective.
ADC Biotechnology was founded in 2010.
ADC Biotechnology operates in Biopharma, Biotechnology and Health Care. Its work centres on ADC Bio, drug development, process technology and conjugation challenges.
ADC Biotechnology has completed 6 funding rounds, raising a total of $16.33M. The latest funding stage is Venture round.
Top alternatives and competitors to ADC Biotechnology include Iksuda Therapeutics, Bright Biologics, Mythic Therapeutics, Inc., Ablexis, LLC, Tagworks Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ADC Biotechnology and Iksuda Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ADC Biotechnology, https://bouncewatch.com/company/adc-biotechnology, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes